Literature DB >> 12615070

Expression and characterization of the olfactomedin domain of human myocilin.

Ildikó Nagy1, Mária Trexler, László Patthy.   

Abstract

The olfactomedin-domain has been first identified in olfactomedin, an extracellular matrix protein of the olfactory neuroepithelium. Members of this extracellular domain-family have since been shown to be present in several metazoan proteins, such as latrophilins, myocilins, and noelins, but their biological function is unknown. The olfactomedin-domain of myocilin is of considerable interest, since mutations affecting this domain are associated with primary open angle glaucoma. In order to define structural features of this domain-type we have expressed the olfactomedin-domain of human myocilin in Pichia pastoris. The olfactomedin-domain contains a single disulphide-bond connecting Cys-245 and Cys-433 residues; secondary structure predictions and circular dichroism studies indicate that it consists primarily of beta-strands. It is noteworthy that the majority of mutations associated with severe forms of glaucoma affect residues that reside in conserved secondary structural elements of the olfactomedin-domain or are otherwise critical for the integrity of this protein-fold.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12615070     DOI: 10.1016/s0006-291x(03)00198-0

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Expression, purification, crystallization and preliminary X-ray analysis of the olfactomedin domain from the sea urchin cell-adhesion protein amassin.

Authors:  Brian J Hillier; Vidyasankar Sundaresan; C David Stout; Victor D Vacquier
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2005-12-16

2.  On the relation between the predicted secondary structure and the protein size.

Authors:  Lukasz Kurgan
Journal:  Protein J       Date:  2008-06       Impact factor: 2.371

3.  The stability of myocilin olfactomedin domain variants provides new insight into glaucoma as a protein misfolding disorder.

Authors:  J Nicole Burns; Katherine C Turnage; Chandler A Walker; Raquel L Lieberman
Journal:  Biochemistry       Date:  2011-06-09       Impact factor: 3.162

4.  The olfactomedin domain from gliomedin is a β-propeller with unique structural properties.

Authors:  Huijong Han; Petri Kursula
Journal:  J Biol Chem       Date:  2014-12-17       Impact factor: 5.157

5.  Rescue of glaucoma-causing mutant myocilin thermal stability by chemical chaperones.

Authors:  J Nicole Burns; Susan D Orwig; Julia L Harris; J Derrick Watkins; Douglas Vollrath; Raquel L Lieberman
Journal:  ACS Chem Biol       Date:  2010-05-21       Impact factor: 5.100

6.  Myocilin, a component of a membrane-associated protein complex driven by a homologous Q-SNARE domain.

Authors:  W Michael Dismuke; Brian S McKay; W Daniel Stamer
Journal:  Biochemistry       Date:  2012-04-18       Impact factor: 3.162

7.  Optimized bacterial expression of myocilin proteins and functional comparison of bacterial and eukaryotic myocilins.

Authors:  Bum-Chan Park; Xiang Shen; Michael P Fautsch; Martin Tibudan; Douglas H Johnson; Beatrice Y J T Yue
Journal:  Mol Vis       Date:  2006-07-31       Impact factor: 2.367

8.  Functional role of proteolytic processing of recombinant myocilin in self-aggregation.

Authors:  José-Daniel Aroca-Aguilar; Francisco Martínez-Redondo; Francisco Sánchez-Sánchez; Miguel Coca-Prados; Julio Escribano
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-08-20       Impact factor: 4.799

Review 9.  Targeting the ER-autophagy system in the trabecular meshwork to treat glaucoma.

Authors:  Andrew R Stothert; Sarah N Fontaine; Jonathan J Sabbagh; Chad A Dickey
Journal:  Exp Eye Res       Date:  2015-08-22       Impact factor: 3.467

10.  Biophysical characterization of the olfactomedin domain of myocilin, an extracellular matrix protein implicated in inherited forms of glaucoma.

Authors:  Susan D Orwig; Raquel L Lieberman
Journal:  PLoS One       Date:  2011-01-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.